Ir Med Inc (IRME) Return on Assets ROA from the second quarter of 2025 to second quarter of 2024 and for the year 2025, Average High and Low, Fundamental Ratios from Jun 30 2025 to Jun 30 2024 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Ir med Inc   (IRME)


Ir Med Inc 's ROA from the second quarter of 2025 to the second quarter of 2024 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Ir Med Inc 's ROA in the second quarter of 2025?
Due to the lack of assets, it was not possible to calculate Ir Med Inc 's return on assets (ROA) in its second quarter of 2025

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Jun 30 2025)
II. Quarter		 (Mar 31 2025)
I. Quarter		 (Dec 31 2024)
IV. Quarter		 (Sep 30 2024)
III. Quarter		 (Jun 30 2024)
II. Quarter
Y / Y Total Assets Change -79.03 % -76.68 % -73.77 % -69.94 % -66.17 %
Y / Y Net Income Change 91.53 % 17.66 % -78.13 % -49.28 % -67 %
Net Income (TTM) in million 2 2 2 3 3
Return On Assets (TTM) 842.29 % 443.59 % 335.96 % 385.86 % 327.8 %
IRME's Total Ranking # 11 # 20 # 18 # 21 # 24
Total Assets (TTM) in million 0 0 0 1 1
Seq. Total Assets Change 37.78 % -48.47 % -50.84 % -39.91 % 53.2 %
Seq. Net Income Change -9.31 % 178.06 % -53.51 % 63.39 % -44.29 %

IRME's 5 Years Annual ROA >> Back to IRME Management Effectiveness >> Compare IRME ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 0
Sector # 0
Overall # 8

Return On Assets Statistics
High Average Low
867.96 %
302.55 %
46.5 %
(Jun 30 2025)   (Sep 30 2022)





Financial Statements
Ir Med Inc 's Assets $ 0 million IRME's Balance sheet
Ir Med Inc 's Income $ 1 million Quarterly IRME's Income Statement
IRME's Income by Division See IRME's Income by Division



Annual Return On Assets (Dec 31 2024)
FY 2024		 (Dec 31 2023)
FY 2023		 (Dec 31 2022)
FY 2022		 (Dec 31 2020)
FY 2021
FY
Y / Y Total Assets Change -73.77 % -69.67 % 35.95 % - -
Total Assets in million 0 1 3 2 0
Y / Y Net Income Change -61.32 % 3.7 % - - -
Net Income in million 2 5 5 -1 0
Annual Return On Assets 724.81 % 491.39 % 143.72 % -31.04 % -

IRME's 5 Years Annual ROA >> Back to IRME Management Effectiveness >> Compare IRME ROA to its Competitors



Comment on IRME's ROA in the fiscal year ending 2024
Despite deterioration in net income of -61.32 % to $1.90 million, Ir Med Inc 's ROA improved in the fiscal year2024 to 724.81 % compared to previous year, as the value of IRME's assets decline even faster to $0.26 million, from $0.26 a year before.


More Return On Assets Ratios
IRME's' Return on Assets at Yahoo Finance
Medical Equipment & Supplies Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
IRME's Roa Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for IRME's Competitors
Subscribers only: Roa for Ir Med Inc 's Suppliers
Subscribers only: Return On Assets for IRME's Customers

You may also want to know
IRME's Roi IRME's Inventory Turnover Ratio IRME's Growth Rates IRME's Dividend Comparisons
IRME's Profitability Ratios IRME's Asset Turnover Ratio IRME's Dividend Growth
IRME's Roe IRME's Valuation Ratios IRME's Financial Strength Ratios IRME's Dividend Payout Ratio



Companies with similar Return On Assets at Jun 30 2025, within Healthcare Sector ROA
Ir med Inc   867.96 %
Vystar Corporation  403.57 %
Glucotrack Inc   402.86 %
Silexion Therapeutics Corp  286.41 %
Pavmed Inc   172.62 %

Date modified: 2026-06-22T14:32:40+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.